|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/06/19 FSD Pharma Inc. 40FR12B 52:25M Newsfile Corp/FA |
Document/Exhibit Description Pages Size
1: 40FR12B Registration of Securities of a Canadian Issuer -- HTML 70K
form40fr12b
2: EX-99.1 Miscellaneous Exhibit -- exhibit99-1 HTML 13K
11: EX-99.10 Miscellaneous Exhibit -- exhibit99-10 HTML 26K
12: EX-99.11 Miscellaneous Exhibit -- exhibit99-11 HTML 192K
13: EX-99.12 Miscellaneous Exhibit -- exhibit99-12 HTML 135K
14: EX-99.13 Miscellaneous Exhibit -- exhibit99-13 HTML 81K
15: EX-99.14 Miscellaneous Exhibit -- exhibit99-14 HTML 41K
16: EX-99.15 Miscellaneous Exhibit -- exhibit99-15 HTML 14K
17: EX-99.16 Miscellaneous Exhibit -- exhibit99-16 HTML 19K
18: EX-99.17 Miscellaneous Exhibit -- exhibit99-17 HTML 615K
19: EX-99.18 Miscellaneous Exhibit -- exhibit99-18 HTML 111K
20: EX-99.19 Miscellaneous Exhibit -- exhibit99-19 HTML 24K
3: EX-99.2 Miscellaneous Exhibit -- exhibit99-2 HTML 16K
21: EX-99.20 Miscellaneous Exhibit -- exhibit99-20 HTML 24K
22: EX-99.21 Miscellaneous Exhibit -- exhibit99-21 HTML 24K
23: EX-99.22 Miscellaneous Exhibit -- exhibit99-22 HTML 141K
24: EX-99.23 Miscellaneous Exhibit -- exhibit99-23 HTML 21K
25: EX-99.24 Miscellaneous Exhibit -- exhibit99-24 HTML 152K
26: EX-99.25 Miscellaneous Exhibit -- exhibit99-25 HTML 236K
27: EX-99.26 Miscellaneous Exhibit -- exhibit99-26 HTML 248K
28: EX-99.27 Miscellaneous Exhibit -- exhibit99-27 HTML 159K
29: EX-99.28 Miscellaneous Exhibit -- exhibit99-28 HTML 260K
30: EX-99.29 Miscellaneous Exhibit -- exhibit99-29 HTML 15K
4: EX-99.3 Miscellaneous Exhibit -- exhibit99-3 HTML 27K
31: EX-99.30 Miscellaneous Exhibit -- exhibit99-30 HTML 12K
32: EX-99.31 Miscellaneous Exhibit -- exhibit99-31 HTML 12K
33: EX-99.32 Miscellaneous Exhibit -- exhibit99-32 HTML 302K
34: EX-99.33 Miscellaneous Exhibit -- exhibit99-33 HTML 27K
35: EX-99.34 Miscellaneous Exhibit -- exhibit99-34 HTML 276K
36: EX-99.35 Miscellaneous Exhibit -- exhibit99-35 HTML 189K
37: EX-99.36 Miscellaneous Exhibit -- exhibit99-36 HTML 238K
38: EX-99.37 Miscellaneous Exhibit -- exhibit99-37 HTML 20K
39: EX-99.38 Miscellaneous Exhibit -- exhibit99-38 HTML 367K
40: EX-99.39 Miscellaneous Exhibit -- exhibit99-39 HTML 444K
5: EX-99.4 Miscellaneous Exhibit -- exhibit99-4 HTML 53K
41: EX-99.40 Miscellaneous Exhibit -- exhibit99-40 HTML 13K
42: EX-99.41 Miscellaneous Exhibit -- exhibit99-41 HTML 21K
43: EX-99.42 Miscellaneous Exhibit -- exhibit99-42 HTML 13K
44: EX-99.43 Miscellaneous Exhibit -- exhibit99-43 HTML 251K
45: EX-99.44 Miscellaneous Exhibit -- exhibit99-44 HTML 32K
46: EX-99.45 Miscellaneous Exhibit -- exhibit99-45 HTML 222K
47: EX-99.46 Miscellaneous Exhibit -- exhibit99-46 HTML 126K
48: EX-99.47 Miscellaneous Exhibit -- exhibit99-47 HTML 492K
49: EX-99.48 Miscellaneous Exhibit -- exhibit99-48 HTML 16K
50: EX-99.49 Miscellaneous Exhibit -- exhibit99-49 HTML 14K
6: EX-99.5 Miscellaneous Exhibit -- exhibit99-5 HTML 41K
51: EX-99.50 Miscellaneous Exhibit -- exhibit99-50 HTML 14K
52: EX-99.51 Miscellaneous Exhibit -- exhibit99-51 HTML 274K
7: EX-99.6 Miscellaneous Exhibit -- exhibit99-6 HTML 50K
8: EX-99.7 Miscellaneous Exhibit -- exhibit99-7 HTML 168K
9: EX-99.8 Miscellaneous Exhibit -- exhibit99-8 HTML 15K
10: EX-99.9 Miscellaneous Exhibit -- exhibit99-9 HTML 118K
| FSD Pharma Inc.: Exhibit 99.8 - Filed by newsfilecorp.com |
FORM 51–102F3
MATERIAL CHANGE REPORT
Item 1 Name and Address of Company
Century Financial Capital Group Inc. (“Century” or the “Company”) Canadian Venture Building
82 Richmond Street East
Toronto, ON M5C 1P1
Item 2 Date of Material Change
Item 3 News Release
The Company disseminated a news release concerning the material change described herein on February 20, 2018 via The Newswire and subsequently filed on SEDAR at www.sedar.com.
Item 4 Summary of Material Change
Century Financial Capital Group Inc. Declares Stock Dividend
Item 5 Full Description of Material Change
5.1 Full Description of Material Change
The Company provided notice that it has declared a stock dividend of one (1) common share for each one (1) existing common share of the Company outstanding, payable on March 16, 2018 to the shareholders of record as of March 5, 2018. Pursuant to the stock dividend, the Company will issue an aggregate of 54,230,732 common shares based on the number of common shares outstanding as of the date hereof.
Registered shareholders will be mailed a letter of transmittal, which will be included with the meeting materials to be mailed to shareholders in connection with the Company’s annual general and special meeting to be held on March 15, 2018 and will be posted on the Company’s SEDAR profile at www.sedar.com. Shareholders that wish to receive a stock certificate for their common shares issued pursuant to the stock dividend will be required to follow the instructions in the letter of transmittal.
5.2 Disclosure for Restructuring Transactions
Not applicable.
Item 6 Reliance on subsection 7.1(2) of National Instrument 51–102
Not applicable.
- 2 -
Item 7 Omitted Information
Not applicable.
Item 8 Executive Officer
Yaron Conforti
CEO
Tel: (416) 716-8181
Item 9 Date of Report
| This ‘40FR12B’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 12/6/19 | None on these Dates | ||
| 3/16/18 | ||||
| 3/15/18 | ||||
| 3/5/18 | ||||
| 2/20/18 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/02/24 FSD Pharma Inc. 20-F 12/31/23 120:15M Blueprint/FA 12/26/23 FSD Pharma Inc. F-3 12/22/23 5:33M Blueprint/FA 3/31/23 FSD Pharma Inc. 20-F 12/31/22 119:14M Newsfile Corp./FA 3/31/22 FSD Pharma Inc. 20-F 12/31/21 132:39M Newsfile Corp./FA 4/02/21 FSD Pharma Inc. F-10 3:235K Newsfile Corp./FA |